EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The C-type lectin domain of CD62P (P-selectin) functions as an integrin ligand

Yoko K Takada, Scott I Simon, Yoshikazu Takada iD

Life Science Alliance · 2023

DOI: 10.26508/lsa.202201747 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Science Alliance, 2023. Verfasst von Yoko K Takada und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, UC Davis School of Medicine, Sacramento, CA, USA. Hauptthemen laut MEDLINE: Lectins, C-Type, P-Selectin, Integrin alphaVbeta3, Cell Adhesion. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NCI, UC | UCD | Comprehensive Cancer Center, University of California, Davis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recognition of integrins by CD62P has not been reported and this motivated a docking simulation using integrin αvβ3 as a target. We predicted that the C-type lectin domain of CD62P functions as a potential integrin ligand and observed that it specifically bound to soluble β3 and β1 integrins. Known inhibitors of the interaction between CD62P–PSGL-1 did not suppress the binding, whereas the disintegrin domain of ADAM-15, a known integrin ligand, suppressed recognition by the lectin domain. Furthermore, an R16E/K17E mutation in the predicted integrin-binding interface located outside of the glycan-binding site within the lectin domain, strongly inhibited CD62P binding to integrins. In contrast, the E88D mutation that strongly disrupts glycan binding only slightly affected CD62P-integrin recognition, indicating that the glycan and integrin-binding sites are distinct. Notably, the lectin domain allosterically activated integrins by binding to the allosteric site 2. We conclude that CD62P-integrin binding may function to promote a diverse set of cell–cell adhesive interactions given that β3 and β1 integrins are more widely expressed than PSGL-1 that is limited to leukocytes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lectins, C-TypeP-SelectinIntegrin alphaVbeta3Cell AdhesionProtein DomainsHumansAnimalsCHO CellsCricetulusRecombinant ProteinsLigandsMutationMembrane GlycoproteinsMembrane ProteinsADAM ProteinsProtein BindingAllosteric SiteCell Communication

Substanzen

Lectins, C-TypeP-SelectinRecombinant ProteinsLigandsIntegrin alphaVbeta3P-selectin ligand proteinMembrane GlycoproteinsADAM15 protein, humanMembrane ProteinsADAM Proteins

Autor:innen und Institutionen

  • Department of Dermatology, UC Davis School of Medicine, Sacramento, CA, USA.
  • Department of Biomedical Engineering, UC Davis, Davis, CA, USA.
  • Department of Dermatology, UC Davis School of Medicine, Sacramento, CA, USA ytakada@ucdavis.edu.
  • Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, Sacramento, CA, USA.

ORCID-Profile: Yoshikazu Takada

Förderung

  • NCI NIH HHS
  • NCI
  • UC | UCD | Comprehensive Cancer Center, University of California, Davis
  • National Cancer Institute

Zitieren

APA

Takada, Y. K., Simon, S. I., & Takada, Y. (2023). The C-type lectin domain of CD62P (P-selectin) functions as an integrin ligand. Life Science Alliance. https://doi.org/10.26508/lsa.202201747

Vancouver

Takada YK, Simon SI, Takada Y. The C-type lectin domain of CD62P (P-selectin) functions as an integrin ligand. Life Science Alliance. 2023. doi:10.26508/lsa.202201747

BibTeX
@article{Takada2023,
  author = {Takada, Yoko K and Simon, Scott I and Takada, Yoshikazu},
  title = {The C-type lectin domain of CD62P (P-selectin) functions as an integrin ligand},
  journal = {Life Science Alliance},
  year = {2023},
  doi = {10.26508/lsa.202201747}
}
Kostenlos starten →